WallStSmart

Covista Inc. (CVSA)vsGenius Group Ltd (GNS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 16183% more annual revenue ($1.95B vs $12.00M). CVSA leads profitability with a 12.9% profit margin vs 0.0%. CVSA earns a higher WallStSmart Score of 71/100 (B).

CVSA

Strong Buy

71

out of 100

Grade: B

Growth: 8.0Profit: 7.5Value: 7.0Quality: 6.0
Piotroski: 4/9Altman Z: 3.06

GNS

Hold

40

out of 100

Grade: D

Growth: 5.3Profit: 2.5Value: 4.0Quality: 4.5
Piotroski: 2/9Altman Z: -0.68
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CVSA.

GNSSignificantly Overvalued (-32.4%)

Margin of Safety

-32.4%

Fair Value

$0.30

Current Price

$0.10

$0.20 premium

UndervaluedFair: $0.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA5 strengths · Avg: 8.4/10
Altman Z-ScoreHealth
3.0610/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.938/10

Growing faster than its price suggests

P/E RatioValuation
17.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

EPS GrowthGrowth
43.2%8/10

Earnings expanding 43.2% YoY

GNS3 strengths · Avg: 9.7/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
128.1%10/10

Revenue surging 128.1% year-over-year

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

Areas to Watch

CVSA0 concerns · Avg: 0/10

No major concerns identified

GNS4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$21.98M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, P/E Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bull Case : GNS

The strongest argument for GNS centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 128.1% demonstrates continued momentum.

Bear Case : CVSA

No major red flags identified for CVSA, but monitor valuation.

Bear Case : GNS

The primary concerns for GNS are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

CVSA profiles as a value stock while GNS is a hypergrowth play — different risk/reward profiles.

GNS carries more volatility with a beta of 9.32 — expect wider price swings.

GNS is growing revenue faster at 128.1% — sustainability is the question.

CVSA generates stronger free cash flow (76M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (71/100 vs 40/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Genius Group Ltd

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Genius Group Limited, offers training and education courses and services. The company is headquartered in Singapore.

Want to dig deeper into these stocks?